Article Listing - Japan pharma stock market - week to October 15

EC PHARMA MARKET LURCHES TO COMPLETION

20 April 1992

The complex issue of creating a unified drug marketing approval regime in the European Comm-unity internal market is outlined in...

SLIGHT RISE IN UCB PRETAX PROFITS

20 April 1992

The Belgian UCB chemical and pharmaceutical group UCB announced a slight rise of 1% in pretax ordinary profits for 1991...

US SENATE PASSES DEBARMENT BILL

20 April 1992

The US Senate passed HR 2454, the Generic Drug Enforcement Act, with some amendments, just before Congress broke for the...

STOCK MARKET COMMENTARY: NEW YORK

20 April 1992

NEW YORK: having lost heavily for the first two reporting days, the Dow Jones failed to close the week...

NEW DIRECTOR AT ABBOTT LABS

20 April 1992

Abbott Laboratories has appointed Addison Barry Rand, executive vice president of Xerox Corp, as a director.

DO ANTIHISTAMINES WORK FOR COLDS?

20 April 1992

The US Food and Drug Administra-tion is to reconsider the labelling claims for over-the-counter antihistamines, which suggest the products may...

JAPAN SEES RECORD RISE IN HIV/AIDS

13 April 1992

Five new cases of AIDS, and 53 of HIV infection were reported to the Japanese Ministry of Health and Welfare's...

US FDA ENFORCEMENT BILL DRAFT

13 April 1992

A new discussion draft of the proposed US Food and Drug Administration enforcement legislation would provide the agency with powers...

BAYER JAPAN PROFITS BOOST

13 April 1992

The Bayer group in Japan, which consists of 15 companies, was able to increase its sales by 1.7% to 219.5...

SUSPENSION OF DPT VACCINE

13 April 1992

Following the decision by the Department of Health in the Republic of China for an immediate temporary suspension of the...

Showing 94491-94500 of 95576 articles

Go to beginningPreviousNextGo to end